197 related articles for article (PubMed ID: 769964)
1. The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis.
Poplack DG; Sher NA; Chaparas SD; Blaese RM
Cancer Res; 1976 Apr; 36(4):1233-7. PubMed ID: 769964
[TBL] [Abstract][Full Text] [Related]
2. Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis.
Sher NA; Poplack DG; Blaese RM; Brown TM; Chaparas SD
J Natl Cancer Inst; 1977 Jun; 58(6):1753-7. PubMed ID: 864753
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis of resident, elicited and immunologically activated murine peritoneal macrophages.
Staer AF; Rhodes JM; Bennedsen J; Olesen Larsen S
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):117-21. PubMed ID: 6880746
[TBL] [Abstract][Full Text] [Related]
4. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
Kramnik I; Radzioch D; Skamene E
Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
[TBL] [Abstract][Full Text] [Related]
5. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
Meltzer MS; Stevenson MM
J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
[No Abstract] [Full Text] [Related]
6. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
Kato K; Yamamoto K; Kimura T
J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
[TBL] [Abstract][Full Text] [Related]
7. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
[TBL] [Abstract][Full Text] [Related]
8. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
[TBL] [Abstract][Full Text] [Related]
9. Mode of immunopotentiating action of BCG: macrophage activation produced by BCG-infection.
Ishibashi T; Harada S; Takamoto M; Harada Y; Yamada H; Miyazaki N; Sugiyama K
Jpn J Exp Med; 1978 Feb; 48(1):35-40. PubMed ID: 353337
[TBL] [Abstract][Full Text] [Related]
10. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
11. Effects of Mycobacterium bovis (strain BCG) on the interstitial cells of hydronephrotic, contralateral, and normal rabbit kidneys.
Thomasson DL; Buck S; Zenser TV; Davis BB
J Reticuloendothel Soc; 1983 Sep; 34(3):195-202. PubMed ID: 6352934
[TBL] [Abstract][Full Text] [Related]
12. Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.
Inoue T; Yoshikai Y; Matsuzaki G; Nomoto K
J Immunol; 1991 Apr; 146(8):2754-62. PubMed ID: 1707921
[TBL] [Abstract][Full Text] [Related]
13. Mouse mononuclear cell chemotaxis: description of system.
Boetcher DA; Meltzer MS
J Natl Cancer Inst; 1975 Mar; 54(3):795-9. PubMed ID: 1091744
[TBL] [Abstract][Full Text] [Related]
14. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
Fisher B; Taylor S; Levine M; Saffer E; Fisher ER
Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
[No Abstract] [Full Text] [Related]
15. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
[TBL] [Abstract][Full Text] [Related]
16. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components.
Rhoades ER; Geisel RE; Butcher BA; McDonough S; Russell DG
Tuberculosis (Edinb); 2005 May; 85(3):159-76. PubMed ID: 15850754
[TBL] [Abstract][Full Text] [Related]
17. The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles).
Lesellier S; Palmer S; Dalley DJ; Davé D; Johnson L; Hewinson RG; Chambers MA
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):24-37. PubMed ID: 16687176
[TBL] [Abstract][Full Text] [Related]
18. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
[TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guerin induced macrophage stimulation: humoral aspects.
Megirian R; Saba TM; Stephenson JB
J Reticuloendothel Soc; 1976 Nov; 20(5):341-8. PubMed ID: 794469
[No Abstract] [Full Text] [Related]
20. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
